Innovation
6 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 360 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 5 |
Social engagement
Social engagement: 3K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Orbimed, RA Capital Management, Forbion.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Accelerator & incubator | 1 | 14% |
| Other / undisclosed | 1 | 14% |
Recent activity
11 Jun 2026
Event
BIO2026 panel discussion on precision medicine approaches
3 Jun 2026
Event
ENDO2026
29 May 2026
Event
85th Scientific Sessions of the American Diabetes Association